Cardiology

Ivabradine shows promise in patients with heart failure with diverse risk profiles

An analysis of the SHIFT trial data indicates that ivabradine, a medication used to reduce heart rate, is effective in improving clinical outcomes for patients with heart failure (HF) across various risk indicators. The study showed that ivabradine produced similar risk reductions in the primary endpoint (cardiovascular death or HF...